aod9604 human clinical trials weight loss results efficacy 💊 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗔𝗢𝗗 𝟵𝟲𝟬𝟰? 💊 AOD 9604 is a modified fragment of growth hormone (HGH) designed to support 𝗳𝗮𝘁 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝘀𝗺 𝗮𝗻𝗱 𝘄𝗲𝗶𝗴𝗵𝘁 𝗹𝗼𝘀𝘀 without impacting blood sugar or causing unwanted What Do Clinical Trials Indicate

AOD9604 was originally developed after research on mice, but subsequent studies in human have shown no efficacy for the potential treatment of obesity

It supports natural energy metabolism, cognitive function, nervous system wellness and nutrient utilization in a general wellness context

Scientific References (External Links) Nature Chemical Biology: Small molecule inhibitors of nicotinamide N-methyltransferase View Study Biochemical Pharmacology: Nicotinamide N-methyltransferase: A promising target for treating metabolic disorders View Study FASEB Journal: Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity in mice View Study Journal of Biological Chemistry: Inhibition of nicotinamide N-methyltransferase in vivo regulates cellular energy metabolism View Study

(e) cross-sectional studies with no time restriction, (f) only studies published in English were included due to resource limitations and to ensure accuracy in data extraction and risk-of-bias assessment